News and Articles

Stay up to date with the latest news and headlines from SCAI.

img

SCAI Statement on Thyroid Monitoring in Young Children Receiving Iodinated Contrast Media

SCAI believes that the current data is insufficient to warrant the course of action described within the recent Food and Drug Administration Drug Safety Communication and that further studies are needed to define at-risk groups accurately, clarify the risks of ICM exposure, and provide rational monitoring and treatment guidelines.

© Society for Cardiovascular Angiography and Interventions

SCAI® is a registered trademark of the Society for Cardiovascular Angiography and Interventions.

All content found on the Society for Cardiovascular Angiography and Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.

Get in touch

1100 17th Street NW, Suite 400, Washington, DC 20036
202-741-9854 TEL
800-992-7224 TOLL-FREE
202-689-7224 FAX
info@scai.org

Connect

Follow us on social media.